7-Amino-1,2,3,4-tetrahydro-2-quinolinone, 97.0%, 10g

anti-1,2,2,3,4,4-Hexamethylphosphetane 1-Oxide>98.0%(GC)5g

Bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, 98.0%, 5g

SODIUM BROMODIFLUOROACETATE, 95%, 1g

7-Bromooxindole, 95.0%, 100g

N-methoxy-N-methyl-2-(4-methylphenyl)acetamide, 95.0%, 2g

N-Cyclopropylbenzylamine, 95.0%, 250mg

(4-((1-ETHOXY-2-METHYL-1-OXOPROPAN-2-YL)OXY)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 5g

(S)-2-(Fluoromethyl)pyrrolidine hydrochloride, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 50 µl, 1705 RNR, 1 piece

Methyl 3-Hydroxyisoxazole-5-carboxylate>98.0%(GC)1g

Sugammadex Sodium>95.0%(HPLC)100mg

Pentafluorophenyl Acetate>98.0%(GC)1g